BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20643449)

  • 21. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
    Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer.
    Dinan MA; Li Y; Zhang Y; Stewart SB; Curtis LH; George DJ; Reed SD
    Clin Genitourin Cancer; 2016 Feb; 14(1):28-37.e2. PubMed ID: 26382223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tracking Cardiac Rehabilitation Participation and Completion Among Medicare Beneficiaries to Inform the Efforts of a National Initiative.
    Ritchey MD; Maresh S; McNeely J; Shaffer T; Jackson SL; Keteyian SJ; Brawner CA; Whooley MA; Chang T; Stolp H; Schieb L; Wright J
    Circ Cardiovasc Qual Outcomes; 2020 Jan; 13(1):e005902. PubMed ID: 31931615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
    Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
    J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Participation in Prostate Cancer Screening among Older Men in Jordan.
    Abuadas MH; Petro-Nustas W; Albikawi ZF
    Asian Pac J Cancer Prev; 2015; 16(13):5377-83. PubMed ID: 26225681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival associated with treatment vs observation of localized prostate cancer in elderly men.
    Wong YN; Mitra N; Hudes G; Localio R; Schwartz JS; Wan F; Montagnet C; Armstrong K
    JAMA; 2006 Dec; 296(22):2683-93. PubMed ID: 17164454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States.
    Prasad SM; Gu X; Lipsitz SR; Nguyen PL; Hu JC
    Cancer; 2012 Mar; 118(5):1260-7. PubMed ID: 21823112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.
    Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
    Eur Urol Oncol; 2018 May; 1(1):37-45. PubMed ID: 31100227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
    Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
    J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act.
    Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Lago-Hernandez C; Chen YW; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Trinh QD; Nguyen PL
    Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):273-9. PubMed ID: 24980272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer.
    Jacobs BL; Yabes JG; Lopa SH; Heron DE; Chang CH; Schroeck FR; Bekelman JE; Kahn JM; Nelson JB; Barnato AE
    Cancer; 2017 Aug; 123(15):2945-2954. PubMed ID: 28301689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients.
    Potosky AL; Merrill RM; Riley GF; Taplin SH; Barlow W; Fireman BH; Lubitz JD
    Health Serv Res; 1999 Jun; 34(2):525-46. PubMed ID: 10357289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of multimorbidity and patient-reported experiences of care with conservative management among elderly patients with localized prostate cancer.
    Fiano RM; Merrick GS; Innes KE; Mattes MD; LeMasters TJ; Shen C; Sambamoorthi U
    Cancer Med; 2020 Aug; 9(16):6051-6061. PubMed ID: 32628817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive Cardiac Rehabilitation Is Markedly Underutilized by Medicare Beneficiaries: RESULTS FROM A 2012-2016 NATIONAL SAMPLE.
    Husaini M; Deych E; Racette SB; Rich MW; Joynt Maddox KE; Peterson LR
    J Cardiopulm Rehabil Prev; 2022 May; 42(3):156-162. PubMed ID: 34508035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost implications and complications of overtreatment of low-risk prostate cancer in the United States.
    Aizer AA; Gu X; Chen MH; Choueiri TK; Martin NE; Efstathiou JA; Hyatt AS; Graham PL; Trinh QD; Hu JC; Nguyen PL
    J Natl Compr Canc Netw; 2015 Jan; 13(1):61-8. PubMed ID: 25583770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999-2006.
    Sathiakumar N; Delzell E; Morrisey MA; Falkson C; Yong M; Chia V; Blackburn J; Arora T; Kilgore ML
    Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):177-83. PubMed ID: 21403668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of State-Level Medicaid Expansion With Treatment of Patients With Higher-Risk Prostate Cancer.
    Liu W; Goodman M; Filson CP
    JAMA Netw Open; 2020 Oct; 3(10):e2015198. PubMed ID: 33026448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials.
    Fallah J; Zhang L; Amatya A; Gong Y; King-Kallimanis B; Bhatnagar V; Weinstock C; Suzman DL; Agrawal S; Chang E; Anscher MS; Chi DC; Xu JX; Brewer JR; Brave MH; Hadadi M; Theoret MR; Kluetz PG; Goldberg KB; Ibrahim A; Tang S; Pazdur R; Beaver JA; Amiri-Kordestani L; Singh H
    Lancet Oncol; 2021 Sep; 22(9):1230-1239. PubMed ID: 34310904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment.
    Yeboa DN; Guzzo T; Mitra N; Christodouleas JP; Haas NB; Vapiwala N; Armstrong K; Bekelman JE
    Urology; 2011 Nov; 78(5):1107-13. PubMed ID: 21943872
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.